alexa
Reach Us +1-218-451-2974
Claassen D | OMICS International
ISSN: 2161-0460

Journal of Alzheimers Disease & Parkinsonism
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Recommended Conferences

14th International Conference on Alzheimer s Disease & Dementia

Zurich, Switzerland

12th World Congress on Alzheimers Disease & Dementia

Budapest, Hungary
Share This Page

Claassen D

Assistant Professor of Neurology at Vanderbilt University and a neurologist specializing in the care of patients with neurodegenerative disorders

Biography

Dr. Daniel Claassen is an Assistant Professor of Neurology at Vanderbilt University and a neurologist specializing in the care of patients with neurodegenerative disorders, with particular interest in patients with cognitive dysfunction and movement disorders. He earned his medical degree from the Medical College of Georgia and completed his Neurology residency training at the Mayo Clinic, in Rochester, MN and postdoctoral training at the University of Virginia, in Charlottesville, VA. He is a past recipient of the American Academy of Neurology clinical research training grant. Dr. Claassen’s research focuses on understanding brain-behavior relationships in the context of the diagnosis and treatment of neurodegenerative diseases.Since 2009, he has focused his research efforts on behavioral studies in neurodegenerative disorders, evaluating the influence of medications on behavior and cognition. His current studies address cognitive changes that account for impulsive compulsive behaviors. Furthermore, he maintains an active clinical and research interest in the utility of functional neuroimaging. Clinically, his expertise in FDG PET quantitation enables improved recognition and diagnostic certainty of neurodegenerative disorders, such as Alzheimer’s disease

Research Interest

Alzheimers Disease,Positron Emission Tomography,Brain Metabolism ,Advances in Alzheimers Therapy,Alzheimers Medicine,Alzheimers Products & Market Analysis,Alzheimers Syntomas,Diagnostic Alzheimer,Electron Tomography,Computated Tomography,Virtual Pathology

Publications
Top